See what trial and studies are currently available at The Lundquist Institute
We are recruiting men in the Los Angeles area for a clinical trial of DMAU for male contraception.
The Lundquist Institute for Biomedical Innovation is a 501(c)3 independent non-profit biomedical research organization that was founded in 1952. The Institute has over more than 120 principal investigators and 400 researchers in total — MD’s, MD/Ph.D.’s, and Ph.D.’s — working on over 1,000 research studies. We are academically affiliated with the David Geffen School of Medicine at UCLA and work in partnership with the Harbor-UCLA Medical Center. Our research is funded by many sources including grants from the NIH and other government entities, Industry and teaching contracts and royalties, as well as private donors and other non-profit foundations.
Dr. Christina Wang is an internationally recognized investigator in male reproductive medicine and biology, leading the efforts to develop a safe, effective, and reversible hormonal male contraceptive. She is a Professor of Medicine and Assistant Dean in Clinical and Translational Sciences at the David Geffen School of Medicine at UCLA. She is the Associate Director of the UCLA Clinical and Translational Science Institute, and a faculty member of the Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and The Lundquist Institute, Torrance, California.
Please let us know if you have any questions or would like more information about participating in our research.
Email us at firstname.lastname@example.org
Call us at 310-222-1873
Text us at 310-341-9323
Let people know they can sign up to your audience and receive updates, or learn more about a product or service.